No. 15-1055
Title:
SmithKline Beecham Corporation, dba GlaxoSmithKline, et al., Petitioners
v.
King Drug Company of Florence, Inc., et al.
Docketed:February 22, 2016
Linked with 15A603
Lower Ct:United States Court of Appeals for the Third Circuit
  Case Nos.:(14-1243)
  Decision Date:June 26, 2015
  Rehearing Denied:September 23, 2015

~~~Date~~~ ~~~~~~~Proceedings  and  Orders~~~~~~~~~~~~~~~~~~~~~
Dec 4 2015 Application (15A603) to extend the time to file a petition for a writ of certiorari from December 22, 2015 to February 20, 2016, submitted to Justice Alito.
Dec 9 2015 Application (15A603) granted by Justice Alito extending the time to file until January 21, 2016.
Dec 17 2015 Application (15A603) to extend further the time from January 21, 2016 to February 20, 2016, submitted to Justice Alito.
Dec 22 2015 Application (15A603) granted by Justice Alito extending the time to file until February 20, 2016.
Feb 19 2016 Petition for a writ of certiorari filed. (Response due March 23, 2016)
Feb 22 2016 Waiver of right of respondents King Drug Company of Florence, Inc., et al. to respond filed.
Feb 24 2016 DISTRIBUTED for Conference of March 18, 2016.
Mar 2 2016 Response Requested . (Due April 1, 2016)
Mar 11 2016 Order extending time to file response to petition to and including May 2, 2016.
Mar 31 2016 Brief amicus curiae of National Association of Manufacturers filed.
Apr 1 2016 Brief amicus curiae of Generic Pharmaceutical Association filed.
Apr 1 2016 Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.
Apr 1 2016 Brief amici curiae of Washington Legal Foundation, et al. filed.
Apr 1 2016 Brief amicus curiae of Allergan PLC filed.
May 2 2016 Brief of respondents King Drug Company of Florence, Inc., et al. in opposition filed.
May 16 2016 Reply of petitioners SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. filed.
May 17 2016 DISTRIBUTED for Conference of June 2, 2016.
Jun 6 2016 The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Oct 3 2016 Brief amicus curiae of United States filed.
Oct 19 2016 DISTRIBUTED for Conference of November 4, 2016.
Oct 19 2016 Supplemental brief of petitioners SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. filed. (Distributed)
Nov 7 2016 Petition DENIED.


~~Name~~~~~~~~~~~~~~~~~~~~~    ~~~~~~~Address~~~~~~~~~~~~~~~~~~   ~~Phone~~~
Attorneys for Petitioners:
Jay P. Lefkowitz Kirkland & Ellis LLP(212) 446-4800
601 Lexington Avenue
New York, NY  10022
lefkowitz@kirkland.com
Party name: SmithKline Beecham Corporation, dba GlaxoSmithKline, et al.
Attorneys for Respondents:
Bruce E. Gerstein Garwin Gerstein & Fisher, LLP(212) 398-0055
    Counsel of Record88 Pine Street
New York, NY  10005
bgerstein@garwingerstein.com
Party name: King Drug Company of Florence, Inc., et al.
Other:
Daniel Simon Francis Hunton & Williams, LLP0202-955-1500
2200 Pennsylvania Avenue, N.W.
Washington, DC  20037
dfrancis@hunton.com
Party name: National Association of Manufacturers
 
Ian Heath Gershengorn Acting Solicitor General(202) 514-2217
United States Department of Justice
950 Pennsylvania Avenue, N.W.
Washington, DC  20530-0001
SupremeCtBriefs@USDOJ.gov
Party name: United States
 
J. Mark Gidley Wite & Casey, LLP(202) 626-3600
701 Thirteenth Street, NW
Washington, DC  20005
mgidley@whitecase.com
Party name: Allergan PLC
 
Mark W. Mosier Covington & Burling LLP(202) 662-6000
One City Center
850 Tenth
Street, NW
Washington, DC  20001
mmosier@cov.com
Party name: Pharmaceutical Research and Manufacturers of America
 
Richard A. Samp Washington Legal Foundation(202) 588-0302
2009 Massachusetts Avenue, N.W.
Washington, DC  20036
rsamp@wlf.org
Party name: Washington Legal Foundation, et al.
 
Melissa Arbus Sherry Latham & Watkins LLP(202)-637-2355
555 Eleventh Street, NW, Suite 1000
Washington, DC  20004
melissa.sherry@lw.com
Party name: Generic Pharmaceutical Association